GlassScriptPhysician profile
Dmitriy Fuzaylov
NPI 1093974040
$1,779.57
in general payments reported to CMS, 2019-2025
16 companies · $83.45 in 2025
The $83.45 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $622 · 2021: $192 · 2022: $178 · 2023: $135 · 2024: $308 · 2025: $83.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $526.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scilex Pharmaceuticals INC. | $473.63 | 2019-2023 | Ztlido |
| Spr Therapeutics, INC | $238.08 | 2024-2025 | Sprint Pns System |
| Horizon Therapeutics Plc | $199.10 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.80 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $147.17 | 2019-2020 | |
| Pfizer INC. | $131.65 | 2019-2021 | |
| Novo Nordisk INC | $109.96 | 2023 | Wegovy |
| Nalu Medical, INC. | $101.37 | 2024 | Nalu Neurostimulation System |
| Assertio Therapeutics, INC. | $33.47 | 2019-2020 | |
| Nevro Corp. | $31.24 | 2024 | Senza |
| Fidia Pharma USA INC. | $21.43 | 2019 | |
| Ibsa Pharma INC. | $21.43 | 2020 | |
| Zimmer Biomet Holdings, INC. | $20.84 | 2024 | Gel-One Cross-Linked Hyaluronate |
| Pacira Therapeutics, INC. | $18.75 | 2020 | |
| Redhill Biopharma INC. | $18.12 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertical Pharmaceuticals, LLC | $14.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dmitriy Fuzaylov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.